TipRanks
Advertisement
Advertisement

DE:RPD Stock Latest News

Royalty Pharma price target raised to $67 from $65 at Morgan Stanley
The FlyRoyalty Pharma price target raised to $67 from $65 at Morgan Stanley
2d ago
RPRX
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
PremiumThe Fly
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
2M ago
RPRX
Royalty Pharma lifts 2026 outlook amid strong cash flows
PremiumCompany Announcements
Royalty Pharma lifts 2026 outlook amid strong cash flows
2M ago
RPRX
Royalty Pharma price target raised to $66 from $59 at Goldman Sachs
PremiumThe Fly
Royalty Pharma price target raised to $66 from $59 at Goldman Sachs
2M ago
RPRX
Royalty Pharma price target raised to $65 from $64 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $65 from $64 at Morgan Stanley
2M ago
RPRX
Royalty Pharma price target raised to $70 from $66 at Citi
PremiumThe FlyRoyalty Pharma price target raised to $70 from $66 at Citi
2M ago
RPRX
Royalty Pharma reports Q2 revenue $647M, consensus $758.88M
Premium
The Fly
Royalty Pharma reports Q2 revenue $647M, consensus $758.88M
2M ago
RPRX
Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront
Premium
The Fly
Royalty Pharma buys royalty interest in AstraZeneca cliramitug for $125M upfront
3M ago
AZN
RPRX
Royalty Pharma price target raised to $65 from $50 at TD Cowen
PremiumThe Fly
Royalty Pharma price target raised to $65 from $50 at TD Cowen
3M ago
RPRX
Royalty Pharma Shareholders Back Board, Pay and Flexibility
PremiumCompany Announcements
Royalty Pharma Shareholders Back Board, Pay and Flexibility
4M ago
8K
RPRX
Royalty Pharma Secures New $1.8 Billion Credit Facility
PremiumCompany Announcements
Royalty Pharma Secures New $1.8 Billion Credit Facility
4M ago
8K
RPRX
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $64 from $63 at Morgan Stanley
5M ago
RPRX
Royalty Pharma price target raised to $58 from $50 at JPMorgan
PremiumThe FlyRoyalty Pharma price target raised to $58 from $50 at JPMorgan
5M ago
RPRX
Royalty Pharma price target raised to $66 from $50 at Citi
Premium
The Fly
Royalty Pharma price target raised to $66 from $50 at Citi
5M ago
RPRX
Royalty Pharma’s Earnings Call Signals Confident Growth
Premium
Company Announcements
Royalty Pharma’s Earnings Call Signals Confident Growth
5M ago
RPRX
Royalty Pharma price target raised to $57 from $51 at UBS
PremiumThe Fly
Royalty Pharma price target raised to $57 from $51 at UBS
6M ago
RPRX
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
PremiumRatings
Royalty Pharma: Leveraged Biopharma Catalysts and De-Risked Royalty Growth Support Further Upside
6M ago
RPRX
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
PremiumCompany Announcements
Royalty Pharma Expands Daraxonrasib Royalty Stake After Milestone
6M ago
8K
RPRX
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
PremiumThe Fly
Royalty Pharma price target raised to $63 from $61 at Morgan Stanley
6M ago
RPRX
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
PremiumThe FlyRoyalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
6M ago
JNJ
RPRX
Zymeworks price target raised to $48 from $33 at Evercore ISI
Premium
The Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
7M ago
RPRX
ZYME
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
Premium
The Fly
Royalty Pharma appoints Kenneth Sun as Senior Vice President, Head of Asia
7M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >